{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:25:29Z","timestamp":1792275929602,"version":"4.4.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.00595","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T06:14:46Z","timestamp":1600928086000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Clinical Features of 50 Patients With Primary Adrenal Lymphoma"],"prefix":"10.3389","volume":"11","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoming","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1530\/EJE-09-0234","article-title":"Recommended evaluation of adrenal incidentalomas is costly, has high falsepositive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion malignant; time for a rethink?","volume":"161","author":"Cawood","year":"2009","journal-title":"Eur J Endocrinol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: european society of endocrinology clinical practice guideline in collaboration with the european network for the study of adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s00277-013-1812-3","article-title":"Primary adrenal lymphoma: a systematic review","volume":"92","author":"Rashidi","year":"2013","journal-title":"Ann Hematol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1530\/eje.0.1470489","article-title":"Long-term follow-up study of patients with adrenal incidentalomas","volume":"147","author":"Libe","year":"2002","journal-title":"Eur J Endocrinol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/qjmed\/hcw174","article-title":"Adrenal lymphoma: presentation, management and prognosis","volume":"110","author":"Laurent","year":"2017","journal-title":"QJM."},{"key":"B6","doi-asserted-by":"publisher","first-page":"bcr2016219136","DOI":"10.1136\/bcr-2017-220549","article-title":"Primary adrenal lymphoma with initial presentation concerning for bilateral adrenal pheochromocytomas","volume":"2017","author":"Joseph","year":"2017","journal-title":"BMJ Case Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.1158\/0008-5472.CAN-07-0212","article-title":"Serum high-density lipoprotein cholesterol and risk of non-hodgkin lymphoma","volume":"67","author":"Lim","year":"2007","journal-title":"Cancer Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1158\/1055-9965.EPI-19-0803","article-title":"Lipid trait variants and the risk of non-hodgkin lymphoma subtypes: a mendelian randomization study","volume":"29","author":"Kleinstern","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"620381","DOI":"10.1155\/2015\/620381","article-title":"Primary bilateral non-hodgkin's lymphoma of the adrenal gland presenting as incidental adrenal masses","volume":"2015","author":"Rizzo","year":"2015","journal-title":"Case Rep Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<379::AID-CNCR24>3.0.CO;2-P","article-title":"Blood lipid profiles in children with acute lymphoblastic leukemia","volume":"83","author":"Halton","year":"1998","journal-title":"Cancer."},{"key":"B11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jacl.2014.09.014","article-title":"Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiency","volume":"9","author":"Moraitis","year":"2015","journal-title":"J Clin Lipidol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1038\/bcj.2015.56","article-title":"IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low\/-) monocytes in B-cell non-Hodgkin lymphoma","volume":"5","author":"Xiu","year":"2015","journal-title":"Blood Cancer J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.17116\/patol20198103159","article-title":"Revised WHO classification of tumors of hematopoietic and lymphoid tissues, 2017 (4th Edition): lymphoid tumors","volume":"81","author":"Polyatskin","year":"2019","journal-title":"Arkh Patol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-09-0113","article-title":"A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy","volume":"15","author":"Choi","year":"2009","journal-title":"Clin Cancer Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"B17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.maturitas.2013.12.009","article-title":"Pheochromocytoma: a review","volume":"77","author":"Tsirlin","year":"2014","journal-title":"Maturitas."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.2169\/internalmedicine.8216-16","article-title":"The clinical and hormonal characteristics of primary adrenal lymphomas: the necessity of early detection of adrenal insufficiency","volume":"56","author":"Harada","year":"2017","journal-title":"Intern Med."},{"key":"B19","first-page":"4694","article-title":"Primary hodgkin lymphoma of the adrenal gland: a unique case presentation","volume":"16","author":"Bourne","year":"2009","journal-title":"Can J Urol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1270","DOI":"10.1097\/MD.0000000000001270","article-title":"Primary adrenal lymphoma possibly associated with epstein-barr virus reactivation due to immunosuppression under methotrexate therapy","volume":"94","author":"Ohkura","year":"2015","journal-title":"Medicine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/modpathol.2009.87","article-title":"Most primary adrenal lymphomas are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis","volume":"22","author":"Mozos","year":"2009","journal-title":"Mod Pathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1097\/00004728-199111000-00030","article-title":"CT of primary adrenal lymphoma","volume":"15","author":"Falchook","year":"1991","journal-title":"J Comput Assist Tomogr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"853","DOI":"10.21037\/qims.2018.09.13","article-title":"CT and MRI of adrenal gland pathologies","volume":"8","author":"Fuqin","year":"2018","journal-title":"Quant Imaging Med Surg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1080\/10428190701636450","article-title":"Non-germinal cell phenotype and bcl-2 expression in primary adrenal diffuse large B-cell lymphoma","volume":"48","author":"Ide","year":"2007","journal-title":"Leuk Lymphoma."},{"key":"B25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1365-2559.2008.03076.x","article-title":"MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type","volume":"53","author":"Yoon","year":"2008","journal-title":"Histopathology."},{"key":"B26","first-page":"534","article-title":"Malignant lymphoma of the adrenal gland: its possible correlation with the Epstein-Barr virus","volume":"9","author":"Ohsawa","year":"1996","journal-title":"Mod Pathol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2174\/1874357901509010007","article-title":"Epstein- barr virus: clinical and epidemiological revisits and genetic basis of oncogenesis","volume":"9","author":"Ali","year":"2015","journal-title":"Open Virol J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00277-006-0200-7","article-title":"Adrenal castleman's disease","volume":"86","author":"M\u00fcssig","year":"2007","journal-title":"Ann Hematol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1756-8722-5-49","article-title":"Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the consortium for improving survival of lymphoma (CISL)","volume":"5","author":"Kim","year":"2012","journal-title":"J Hematol Oncol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/2162-3619-2-19","article-title":"Clinicopathological analysis of primary adrenal diffuse large B-cell lymphoma: effectiveness of rituximab-containing chemotherapy including central nervous system prophylaxis","volume":"2","author":"Ichikawa","year":"2013","journal-title":"Exp Hematol Oncol."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00595\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T06:14:59Z","timestamp":1600928099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00595\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,24]]},"references-count":30,"alternative-id":["10.3389\/fendo.2020.00595"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.00595","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,24]]},"article-number":"595"}}